Chemicals - Specialty
Compare Stocks
2 / 10Stock Comparison
EMN vs AVNT
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
EMN vs AVNT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Chemicals - Specialty | Chemicals - Specialty |
| Market Cap | $8.66B | $3.47B |
| Revenue (TTM) | $8.64B | $3.26B |
| Net Income (TTM) | $399M | $82M |
| Gross Margin | 19.8% | 31.7% |
| Operating Margin | 9.4% | 6.4% |
| Forward P/E | 12.8x | 12.4x |
| Total Debt | $5.08B | $1.92B |
| Cash & Equiv. | $566M | $511M |
EMN vs AVNT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Eastman Chemical Co… (EMN) | 100 | 111.3 | +11.3% |
| Avient Corporation (AVNT) | 100 | 152.7 | +52.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: EMN vs AVNT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
EMN is the clearest fit if your priority is long-term compounding.
- 36.1% 10Y total return vs AVNT's 28.8%
- 4.6% margin vs AVNT's 2.5%
- 4.4% yield, 12-year raise streak, vs AVNT's 2.8%
AVNT carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 14 yrs, beta 1.19, yield 2.8%
- Rev growth 0.6%, EPS growth -51.6%, 3Y rev CAGR -1.4%
- Lower volatility, beta 1.19, Low D/E 80.6%, current ratio 1.66x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 0.6% revenue growth vs EMN's -6.7% | |
| Value | Lower P/E (12.4x vs 12.8x) | |
| Quality / Margins | 4.6% margin vs AVNT's 2.5% | |
| Stability / Safety | Beta 1.19 vs EMN's 1.36, lower leverage | |
| Dividends | 4.4% yield, 12-year raise streak, vs AVNT's 2.8% | |
| Momentum (1Y) | +9.8% vs EMN's +3.9% | |
| Efficiency (ROA) | 2.6% ROA vs AVNT's 1.4%, ROIC 6.7% vs 3.9% |
EMN vs AVNT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
EMN vs AVNT — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Evenly matched — EMN and AVNT each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
EMN is the larger business by revenue, generating $8.6B annually — 2.6x AVNT's $3.3B. Profitability is closely matched — net margins range from 4.6% (EMN) to 2.5% (AVNT). On growth, AVNT holds the edge at +1.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $8.6B | $3.3B |
| EBITDAEarnings before interest/tax | $1.2B | $395M |
| Net IncomeAfter-tax profit | $399M | $82M |
| Free Cash FlowCash after capex | $498M | $195M |
| Gross MarginGross profit ÷ Revenue | +19.8% | +31.7% |
| Operating MarginEBIT ÷ Revenue | +9.4% | +6.4% |
| Net MarginNet income ÷ Revenue | +4.6% | +2.5% |
| FCF MarginFCF ÷ Revenue | +5.8% | +6.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | -4.9% | +1.9% |
| EPS Growth (YoY)Latest quarter vs prior year | -40.8% | -65.4% |
Valuation Metrics
EMN leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 18.5x trailing earnings, EMN trades at a 57% valuation discount to AVNT's 42.5x P/E. On an enterprise value basis, EMN's 9.1x EV/EBITDA is more attractive than AVNT's 12.5x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $8.7B | $3.5B |
| Enterprise ValueMkt cap + debt − cash | $13.2B | $4.9B |
| Trailing P/EPrice ÷ TTM EPS | 18.47x | 42.52x |
| Forward P/EPrice ÷ next-FY EPS est. | 12.85x | 12.39x |
| PEG RatioP/E ÷ EPS growth rate | 5.75x | — |
| EV / EBITDAEnterprise value multiple | 9.12x | 12.54x |
| Price / SalesMarket cap ÷ Revenue | 0.99x | 1.06x |
| Price / BookPrice ÷ Book value/share | 1.45x | 1.46x |
| Price / FCFMarket cap ÷ FCF | 20.43x | 17.80x |
Profitability & Efficiency
EMN leads this category, winning 5 of 8 comparable metrics.
Profitability & Efficiency
EMN delivers a 6.7% return on equity — every $100 of shareholder capital generates $7 in annual profit, vs $3 for AVNT. AVNT carries lower financial leverage with a 0.81x debt-to-equity ratio, signaling a more conservative balance sheet compared to EMN's 0.84x.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +6.7% | +3.5% |
| ROA (TTM)Return on assets | +2.6% | +1.4% |
| ROICReturn on invested capital | +6.7% | +3.9% |
| ROCEReturn on capital employed | +7.5% | +4.0% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 |
| Debt / EquityFinancial leverage | 0.84x | 0.81x |
| Net DebtTotal debt minus cash | $4.5B | $1.4B |
| Cash & Equiv.Liquid assets | $566M | $511M |
| Total DebtShort + long-term debt | $5.1B | $1.9B |
| Interest CoverageEBIT ÷ Interest expense | 2.22x | 2.10x |
Total Returns (Dividends Reinvested)
Evenly matched — EMN and AVNT each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AVNT five years ago would be worth $8,041 today (with dividends reinvested), compared to $7,381 for EMN. Over the past 12 months, AVNT leads with a +9.8% total return vs EMN's +3.9%. The 3-year compound annual growth rate (CAGR) favors EMN at 1.9% vs AVNT's 1.9% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +19.0% | +20.2% |
| 1-Year ReturnPast 12 months | +3.9% | +9.8% |
| 3-Year ReturnCumulative with dividends | +6.0% | +5.8% |
| 5-Year ReturnCumulative with dividends | -26.2% | -19.6% |
| 10-Year ReturnCumulative with dividends | +36.1% | +28.8% |
| CAGR (3Y)Annualised 3-year return | +1.9% | +1.9% |
Risk & Volatility
Evenly matched — EMN and AVNT each lead in 1 of 2 comparable metrics.
Risk & Volatility
AVNT is the less volatile stock with a 1.19 beta — it tends to amplify market swings less than EMN's 1.36 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. EMN currently trades 90.0% from its 52-week high vs AVNT's 84.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.36x | 1.19x |
| 52-Week HighHighest price in past year | $84.18 | $44.85 |
| 52-Week LowLowest price in past year | $56.11 | $27.48 |
| % of 52W HighCurrent price vs 52-week peak | +90.0% | +84.4% |
| RSI (14)Momentum oscillator 0–100 | 62.8 | 51.6 |
| Avg Volume (50D)Average daily shares traded | 1.5M | 622K |
Analyst Outlook
Evenly matched — EMN and AVNT each lead in 1 of 2 comparable metrics.
Analyst Outlook
Wall Street rates EMN as "Buy" and AVNT as "Buy". Consensus price targets imply 27.9% upside for AVNT (target: $48) vs 2.0% for EMN (target: $77). For income investors, EMN offers the higher dividend yield at 4.35% vs AVNT's 2.84%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $77.29 | $48.40 |
| # AnalystsCovering analysts | 35 | 20 |
| Dividend YieldAnnual dividend ÷ price | +4.4% | +2.8% |
| Dividend StreakConsecutive years of raises | 12 | 14 |
| Dividend / ShareAnnual DPS | $3.30 | $1.08 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.2% | +0.1% |
EMN leads in 2 of 6 categories — strongest in Valuation Metrics and Profitability & Efficiency. 4 categories are tied.
EMN vs AVNT: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is EMN or AVNT a better buy right now?
For growth investors, Avient Corporation (AVNT) is the stronger pick with 0.
6% revenue growth year-over-year, versus -6. 7% for Eastman Chemical Company (EMN). Eastman Chemical Company (EMN) offers the better valuation at 18. 5x trailing P/E (12. 8x forward), making it the more compelling value choice. Analysts rate Eastman Chemical Company (EMN) a "Buy" — based on 35 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — EMN or AVNT?
On trailing P/E, Eastman Chemical Company (EMN) is the cheapest at 18.
5x versus Avient Corporation at 42. 5x. On forward P/E, Avient Corporation is actually cheaper at 12. 4x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — EMN or AVNT?
Over the past 5 years, Avient Corporation (AVNT) delivered a total return of -19.
6%, compared to -26. 2% for Eastman Chemical Company (EMN). Over 10 years, the gap is even starker: EMN returned +36. 1% versus AVNT's +28. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — EMN or AVNT?
By beta (market sensitivity over 5 years), Avient Corporation (AVNT) is the lower-risk stock at 1.
19β versus Eastman Chemical Company's 1. 36β — meaning EMN is approximately 14% more volatile than AVNT relative to the S&P 500. On balance sheet safety, Avient Corporation (AVNT) carries a lower debt/equity ratio of 81% versus 84% for Eastman Chemical Company — giving it more financial flexibility in a downturn.
05Which is growing faster — EMN or AVNT?
By revenue growth (latest reported year), Avient Corporation (AVNT) is pulling ahead at 0.
6% versus -6. 7% for Eastman Chemical Company (EMN). On earnings-per-share growth, the picture is similar: Eastman Chemical Company grew EPS -46. 5% year-over-year, compared to -51. 6% for Avient Corporation. Over a 3-year CAGR, AVNT leads at -1. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — EMN or AVNT?
Eastman Chemical Company (EMN) is the more profitable company, earning 5.
4% net margin versus 2. 5% for Avient Corporation — meaning it keeps 5. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EMN leads at 10. 6% versus 6. 2% for AVNT. At the gross margin level — before operating expenses — AVNT leads at 32. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is EMN or AVNT more undervalued right now?
On forward earnings alone, Avient Corporation (AVNT) trades at 12.
4x forward P/E versus 12. 8x for Eastman Chemical Company — 0. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AVNT: 27. 9% to $48. 40.
08Which pays a better dividend — EMN or AVNT?
All stocks in this comparison pay dividends.
Eastman Chemical Company (EMN) offers the highest yield at 4. 4%, versus 2. 8% for Avient Corporation (AVNT).
09Is EMN or AVNT better for a retirement portfolio?
For long-horizon retirement investors, Avient Corporation (AVNT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.
19), 2. 8% yield). Both have compounded well over 10 years (AVNT: +28. 8%, EMN: +36. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between EMN and AVNT?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: EMN is a small-cap income-oriented stock; AVNT is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.